FDA Inspection 1016658 — Wuhan Chinese Moxibustion Technology Dev. Co., Ltd.
The FDA completed an inspection of Wuhan Chinese Moxibustion Technology Dev. Co., Ltd. on May 26, 2017 in Wuhan. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- May 26, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Wuhan (China)